looking beyond the smokescreen Cigarette smoking is as strongly related to death from chronic bronchitis and emphysema as it is to mortality from lung cancer.' Symptoms of cough, phlegm, wheeze, and breathlessness are also much more common among individuals and populations who smoke, and are reduced when they quit the habit.2 A randomised controlled trial reported in this issue3 reinforces the simple public health message: when it comes to cigarettes, a change is not as good as a rest.
Cigarette smoking in many developed countries is on the decline (though regrettably increasing in popularity elsewhere). In Britain, current smokers have been in the minority among adults ofboth sexes since the late 1970s and, if current trends continue, less than one quarter of the population will be active smokers by the year 2000. How will the problem of chronic respiratory disease change as smoking declines and other causes which have for so long been obscured by the effects of smoking increasingly require investigation and control ? It is likely that, even if smoking were entirely eliminated, a substantial burden of chronic respiratory morbidity would remain. Respiratory symptoms and illnesses are not uncommon in lifelong non-smokers, as illustrated by data from the British 1946 cohort reported in this issue. 4 Reduced levels of ventilatory function would also remain of concern as a risk factor for (even if not a cause of) all mortality. 5 The decline in smoking among British men in recent decades has been accompanied by a fall in the prevalence of phlegm and breathlessness, but not of wheeze, despite the fact that wheeze is more commonly reported by cigarette smokers. A number of recent observations may be relevant to the explanation of social class trends in chronic respiratory disease, and each, in its own right, opens an exciting new research agenda.
In the aforementioned survey of Hertfordshire men,9 reduced levels of ventilatory function and increased mortality from chronic respiratory disease were observed among men of low birthweight. Intrauterine growth retardation could plausibly result in submaximal lung capacity in early adult life, but a normal rate of functional decline might be expected thereafter. With 16 The inconsistency between men and women is puzzling but may be due to the relatively small numbers hitherto studied. A large international study has been mounted to clarify the contribution of dietary sodium to respiratory morbidity in adults.
Air pollution After an interval of two or three decades, air pollution is back on the political and research agenda. Few students of epidemiology are unaware of the acute effects of smoke and sulphur dioxide air pollution in the London smog episode of December 1952. Less well known is the observation that a temporal relationship between daily smoke and daily deaths in Greater London persisted, at least into the mid-1970s, at all levels of particulate pollution; indeed the dose-response relationship was steeper at low levels of pollution. '7 On the other hand, time trends in mortality from chronic respiratory disease offer no clear evidence of a reduction attributable to the control of smoke and (to a lesser extent) sulphur dioxide air pollution in urban Britain. ' smoking reduction address specifically the problem of smoking among pregnant women and their partners. Unless action in this area is intensified, then it is possible that the smokescreen around respiratory disease will linger for a generation longer than might otherwise be anticipated.
